Kelly Blackburn
Chief Tech/Sci/R&D Officer at CERVOMED INC.
Net worth: 258 986 $ as of 2024-05-30
Kelly Blackburn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CERVOMED INC. | Chief Tech/Sci/R&D Officer | 2023-08-15 | - |
Bach Pharma, Inc.
 Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Director/Board Member | 2016-07-14 | - |
| Chief Executive Officer | 2016-07-14 | - |
Career history of Kelly Blackburn
Former positions of Kelly Blackburn
| Companies | Position | Start | End |
|---|---|---|---|
| ATYR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2013-08-13 | 2016-06-30 |
| VERTEX, INC. | Chief Tech/Sci/R&D Officer | 2006-08-31 | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2002-08-31 | 2006-07-31 |
Training of Kelly Blackburn
| University of New Hampshire | Undergraduate Degree |
| Cambridge College Lima SRL | Graduate Degree |
| Quinnipiac College, Inc. | Graduate Degree |
Statistics
International
| United States | 7 |
| Peru | 2 |
| 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| VERTEX, INC. | Technology Services |
| Private companies | 3 |
|---|---|
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Health Technology |
| CervoMed, Inc. | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kelly Blackburn
- Experience
